|
|
Volumn 33, Issue 7-8, 2001, Pages 3502-3503
|
|
Clinical islet transplant - State of the art
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
C PEPTIDE;
CALCINEURIN INHIBITOR;
HEPARIN;
IMMUNOSUPPRESSIVE AGENT;
INFLIXIMAB;
INSULIN;
INTERLEUKIN 2 RECEPTOR ANTIBODY;
RAPAMYCIN;
TACROLIMUS;
BLOOD GROUP ABO SYSTEM;
CLINICAL PROTOCOL;
CYTOMEGALOVIRUS INFECTION;
DIABETES CONTROL;
DISEASE DURATION;
DRUG BLOOD LEVEL;
FOLLOW UP;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INSULIN DEPENDENT DIABETES MELLITUS;
INSULIN RESISTANCE;
KIDNEY FUNCTION;
LYMPHOCYTE PROLIFERATION;
MALIGNANT NEOPLASTIC DISEASE;
NEPHROTOXICITY;
NEUROTOXICITY;
PANCREAS ISLET TRANSPLANTATION;
PORTAL VEIN;
POSTOPERATIVE HEMORRHAGE;
POSTOPERATIVE THROMBOSIS;
PRIORITY JOURNAL;
QUALITY OF LIFE;
RISK BENEFIT ANALYSIS;
SHORT SURVEY;
TREATMENT OUTCOME;
|
|
EID: 0035671794
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(01)02416-2 Document Type: Article |
|
Times cited : (24)
|
|
References (0)
|
